Dr. Jeff Kwong

Areas of Expertise

• epidemiology
• vaccines
• influenza
• public health
• health services

Appointments

Senior scientist, Institute for Clinical Evaluative Sciences

Associate professor, Dalla Lana School of Public Health, University of Toronto

Associate scientist, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre

Family physician, Toronto Western Family Health Team

Associate professor, Department of Family and Community Medicine, University of Toronto

Academic Degrees and Accreditations

• Doctor of Medicine, University of Toronto
• Master of Science (Epidemiology), University of Toronto
• College of Family Physicians of Canada (CCFP), Family Medicine
• Fellow, The Royal College of Physicians of Canada (FRCPC), Public Health and Preventive Medicine

PHO Research Interests

• Infectious diseases epidemiology and health services research using linkable data.
• Influenza vaccine and vaccination program evaluation (vaccine coverage, vaccine effectiveness, vaccine safety, vaccination program strategies [e.g., universal, school-based]).
• Assessing the health and economic burden of infectious diseases.

PHO Research Activities

• Estimating influenza vaccine effectiveness against laboratory-confirmed serious outcomes in high-risk populations (older adults, young children, individuals with chronic conditions).
• Examining the association between laboratory-confirmed influenza and acute cardiovascular events (myocardial infarctions and ischemic stroke).
• Evaluating the effectiveness and cost-effectiveness of health care worker vaccinate-or-mask influenza prevention policies. Canadian Immunization Research Network (CIRN) Provincia Collaborative Network (PCN): assessing pertussis vaccine effectiveness.
• Estimating longitudinal health care costs for infectious diseases using administrative data.
• Provide expertise in epidemiological study design and analysis, and facilitate access to the extensive population-based data holdings at the Institute for Clinical Evaluative Sciences, for studies the health impacts of air pollutants, the epidemiology of mycobacterial infections and the epidemiology and economic burden of viral hepatitis.

Selected Publications

1. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345-53.
2. Buchan SA, Booth S, Scott AN, Simmonds KA, Svenson LW, Drews SJ, Russell ML, Crowcroft NS, Loeb M, Warshawsky BF, Kwong JC. Effectiveness of live attenuated vs inactivated influenza vaccines in children during the 2012-13 through 2015-16 influenza seasons in Alberta, Canada: a Canadian Immunization Research Network (CIRN) study. JAMA Pediatrics. 2018;e181514.
3. Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, et al, Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination. Vaccine. 2015;33(38):4910-5.
4. Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis. 2013;13(9):769-76.
5. Kwong JC, Campitelli MA, Gubbay JB, Peci A, Winter AL, Olsha R, Tet al. Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among elderly adults during the 2010-2011 season. Clin Infect Dis. 2013;57(6):820-7.

View more publications by Dr. Jeff Kwong on PubMed.gov